Vida Clinical Studies | Dearborn, MI
Status and phase
Conditions
Treatments
About
Trial to Evaluate the Efficacy and Safety of Nitazoxanide (NTZ) for Pre- and Post Exposure Prophylaxis of COVID-19 and Other Viral Respiratory Illnesses (VRI) in Healthcare Workers and Others at Increased Risk of SARS-CoV-2 Infection
Full description
Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial to Evaluate the Efficacy and Safety of Nitazoxanide (NTZ) for Pre- and Post Exposure Prophylaxis of COVID-19 and Other Viral Respiratory Illnesses (VRI) in Healthcare Workers and Others at Increased Risk of SARS-CoV-2 Infection
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Males and females at least 18 years of age or of legal consenting age based on local requirements.
Persons at increased risk of contracting COVID-19, including:
Must have a smartphone, tablet, computer, or other qualifying internet- enabled device and daily internet access.
Occupational exposure to a person infected with SAR-CoV-2 within 7 days prior to enrollment or social interaction as defined in criterion 2(b).
Willing and able to provide written informed consent and comply with the requirements of the protocol, including completion of the subject diary.
Exclusion criteria
Primary purpose
Allocation
Interventional model
Masking
1,407 participants in 2 patient groups, including a placebo group
Loading...
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal